Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/2/2011

expenses between periods were primarily due to planned increases in employee headcount and related costs, legal costs, and selected pre-launch spending for carfilzomib.

Onyx recorded $5.9 million of non-cash contingent consideration expense in the third quarter 2011 associated with changes in the fair value of the liability for contingent consideration recorded for the potential milestone payments under the Proteolix acquisition.

Interest ExpenseInterest expense of $5.1 million for the third quarter 2011 primarily relates to the 4.0% convertible senior notes due 2016 issued in August 2009 and includes non-cash imputed interest expense of $2.6 million as a result of the application of ASC 470-20.

Cash, Cash Equivalents and Marketable SecuritiesOn September 30, 2011, cash, cash equivalents, and current and non-current marketable securities were $529.7 million compared to $577.9 million at December 31, 2010. This excludes restricted cash of $31.9 million at December 31, 2010.  Subsequent to September 30, 2011, the Company received $160 million as part of the sale of Nexavar royalties in Japan, to Bayer.

Nine-Month ResultsNexavar net sales, as recorded by Bayer, were $731.5 million and $676.7 million for the nine months ended September 30, 2011 and 2010, respectively. Non-GAAP net loss for the nine months ended September 30, 2011 was $60.9 million, or $0.96 per diluted share, compared to non-GAAP net income of $56.6 million, or $0.90 per diluted share for the same period in 2010. A description of the non-GAAP calculations is provided below in the accompanying table entitled "Reconciliation of GAAP to Non-GAAP Net Income (Loss)." For the nine months ended September 30, 2011, on a GAAP basis Onyx recorded a net loss of $140.6 million, or $2.22 per diluted share, compared with a net loss of $67.7 million, or $1.08 per diluted share, for the same period in 2010.

Management Conference Call TodayO
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015   Polymedco is committed to ...  During CRC Awareness Month, we are offering all existing ... , Posters – to be hung in ... CRC Patient Brochures with Stand – to be placed ... – to be put on/in patient charts as a ...
(Date:3/2/2015)... HACKENSACK, N.J. , March 2, 2015  Champions ... development of advanced technology solutions and services to personalize ... a 30 day extension on the $2 million convertible ... on December 1, 2014.  Dr. ... remarked, "Champions continues to benefit from the confidence and ...
(Date:3/2/2015)... 2, 2015  Kush Bottles, North ... solutions for the marijuana industry, announced today that ... been nominated for a 2015 Excellence in Entrepreneurship ... Award is designed to recognize individuals who exemplify ... their creativity and determination, have established and nurtured ...
Breaking Medicine Technology:Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2
... Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership ... is now authorized to distribute and sell GenericsWeb ... Head of Partner Relations Department, mentioned in her comments ... whose title speaks for itself – the company focuses ...
... 2010 DURECT Corporation (Nasdaq: DRRX ) today ... and Pain Therapeutics, Inc. (Nasdaq: PTIE ) have ... for REMOXY® to the U.S. Food and Drug Administration (FDA) ... Therapeutics in December 2008.  This is a Class 2 resubmission ...
Cached Medicine Technology:Market Publishers Ltd and GenericsWeb Sign Partnership Agreement 2Market Publishers Ltd and GenericsWeb Sign Partnership Agreement 3REMOXY® New Drug Application Resubmitted 2REMOXY® New Drug Application Resubmitted 3
(Date:3/2/2015)... 02, 2015 A cocaine snorting ... from the typical nip slip or scathing scuffle. A ... is dawning the streets of Hollywood as Paper Jesus’ ... drug addiction and substance abuse in Hollywood. The Oscar ... take a political stance on the travails of drug ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... Buffett tickets at the Hollywood Bowl . This popular ... add customer appreciation promo code JIMMY-BUFFETT-2015 for added savings. ... because their favorite performer will be headlining at the ... This concert will be on Thursday, October 22nd and ...
(Date:3/2/2015)... 02, 2015 “ Wants and Needs ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this app helps people evaluate priorities. , Whether a ... Wants and Needs app. The app allows people to ...
(Date:3/2/2015)... 02, 2015 Tyrone Christopher, Co-founder of ... medium for the model agency industry, have launched Softcandy.sexy, ... Mango, Passion Fruit, Pink Grapefruit, Pomegranate, and or Vanilla ... 1pm. , At a cost of alienating a few ... fire by announcing the brands commitment and support of ...
(Date:3/2/2015)... 02, 2015 ZoomCare announced today ... American healthcare. Zoom will expand its Portland on-demand ... and advanced care studios delivering urgent care, primary ... specialty care and outpatient surgery. With its new ... almost all healthcare needs outside of hospitalization. , ...
Breaking Medicine News(10 mins):Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3
... - Biopharmaceutical researchers have found a protein in blood ... cancer but which rarely shows up in the blood ... might help physicians decide whether smokers or others at ... lung imaging, say investigators, who presented their findings today ...
... In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), ... stimulants is associated with improved long-term academic success ... are the first population-based data to show stimulant ... A related Mayo Clinic study reveals that compared ...
... for,International Development (USAID) today announced that Michael E. ... and,Humanitarian Assistance, is traveling to Zimbabwe, South Africa, ... his portfolio, Hess,oversees the USAID offices of Food ... and Governance., Hess,s regional trip will focus ...
... As predicted by opponents,to "assisted suicide," those seeking to ... slope,. Supporters of "assisted suicide,",including a few members of ... free counseling sessions -- via a new 1-800 number ... own lives. "This effort to put a clerical ...
... on the Importance of Physical Activity,for Adults and ... the nearly 100,million Americans who are overweight or ... weight loss and better health, which is the ... Physical Therapy,Association (APTA) announced today., According to ...
... generated by a 2002 study on the potential dangers ... the Stanford University School of Medicine found that only ... two years later. , Additionally, the women were able ... to hormone therapy just 40 percent of the time. ...
Cached Medicine News:Health News:Blood protein detects lung cancer, even at earliest stage 2Health News:Mayo Clinic study indicates medication for ADHD may help student outcomes 2Health News:Mayo Clinic study indicates medication for ADHD may help student outcomes 3Health News:USAID Assistant Administrator Hess Travels to Southern Africa 2Health News:This October, the American Physical Therapy Association's National Physical Therapy Month to Focus on Nation's Obesity Epidemic 2Health News:This October, the American Physical Therapy Association's National Physical Therapy Month to Focus on Nation's Obesity Epidemic 3Health News:This October, the American Physical Therapy Association's National Physical Therapy Month to Focus on Nation's Obesity Epidemic 4Health News:Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds 2Health News:Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds 3
... Tiburon™ surgical drapes from Cardinal Health will ... and draping in your facility. , ,Shrinking ... be carefully controlled at every turn without ... patient outcomes. Each decision must be evaluated ...
... Drape features less aggressive adhesive strip ... strip for easy removal, aggressive incise ... poly film, and product number identification. ... box of 5 or non-sterile in ...
... includes bed side and near patient testing ... This growth has posed unique problems for ... and quality responsibility to decentralized areas focused ... Compounding the problem is the reality of ...
... System includes genomic DNA Arrays, ... reagents. By utilizing Vysis' patented ... for multi-target assessment, the GenoSensor ... genomic targets in a single ...
Medicine Products: